| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8612489 | Clinical Breast Cancer | 2018 | 22 Pages |
Abstract
NSM is oncologically acceptable in this patient cohort. Patients with large central tumors who undergo NAC should be reconsidered after completion of chemotherapy because many might convert to successful nipple-areolar preservation.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Priya Jadeja, Richard Ha, Christine Rohde, Jeffrey Ascherman, Robert Grant, Christine Chin, Eileen Connolly, Kevin Kalinsky, Sheldon Feldman, Bret Taback,